The biology and mechanism of action of suppressor of cytokine signaling 3

Growth Factors

Volumn 30, Issue 4, 2012, Pages 207-219

  Babon, Jeffrey J ^a,b   Nicola, Nicos A ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cytokine receptor; Cytokine signaling; JAK; SOCS3; STAT; Suppressor of cytokine signaling 3

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CULLIN; CYTOKINE RECEPTOR; ELONGIN B; ELONGIN C; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 6; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; LEPTIN; PROTEIN SH2; PROTEIN TYROSINE KINASE; STAT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UBIQUITIN PROTEIN LIGASE E3;

ARTICLE; BRAIN REGION; CATALYSIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SPECIFICITY; EYE; GENE DELETION; HEMATOPOIETIC SYSTEM; HUMAN; IMMUNE SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BRAIN; CATALYSIS; CYTOKINES; GENE DELETION; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-11; INTERLEUKIN-6; JANUS KINASES; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84865335926     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2012.687375     Document Type: Article

References (95)

1. Anderson P Sundstedt A Li L O'Neill EJ Li SL Wraith DC Wang P. 2003. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int Immunol 15:1309-1317.
2. Babon JJ Yao SG DeSouza DP Harrison CF Fabri LJ Liepinsh E Scrofani SD Baca M Norton RS. 2005. Secondary structure assignment of mouse SOCS3 by NMR defines the domain boundaries and identifies an unstructured insertion in the SH2 domain. FEBS J 272:6120-6130.
3. Babon JJ McManus EJ Yao SG DeSouza DP Mielke LA Sprigg NS Willson TA Hilton DJ Nicola NA Baca M Nicholson SE Norton RS. 2006. The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. Mol Cell 22:205-216.
4. Babon JJ Sabo JK Soetopo A Yao SG Bailey MF Zhang JG Nicola NA Norton RS. 2008. The SOCS box domain of SOCS3: Structure and interaction with the elonginBC-Cullin5 ubiquitin ligase. J Mol Biol 381:928-940.
5. Babon JJ Sabo JK Zhang JG Nicola NA Norton RS. 2009. The SOCS box encodes a hierarchy of affinities for Cullin5: Implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol 387:162-174.
6. Babon JJ Kershaw NJ Murphy JM Varghese L Laktyushin A Lucet IS Norton RS Nicola NA. 2011. Suppression of cytokine signaling by SOCS3: Characterization of the mode of inhibition and the basis of its specificity. Immunity 36:239-250.
7. Banks AS Li J McKeag L Hribal ML Kashiwada M Accili D Rothman PB. 2005. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. J Clin Invest 115:2462-2471.
8. Bergamin E Wu J Hubbard SR. 2006. Structural basis for phosphotyrosine recognition by suppressor of cytokine signaling- 3. Structure 14:1285-1292.
9. Bjorbaek C Elmquist JK Frantz JD Shoelson SE Flier JS. 1998. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1:619-625.
10. Bjorbaek C Lavery HJ Bates SH Olson RK Davis SM Flier JS Myers MG. 2000. SOCS3 mediates feedback inhibition of the leptin receptor via Tyr(985). J Biol Chem 275:40649-40657.
11. Boyle K Egan P Rakar S Willson TA Wicks IP Metcalf D Hilton DJ Nicola NA Alexander WS Roberts AW Robb L. 2007. The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo. Blood 110:1466-1474.
12. Boyle K Zhang JG Nicholson SE Trounson E Babon JJ McManus EJ Nicola NA Robb L. 2009. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal 21:394-404.
13. Brender C Tannahill GM Jenkins BJ Fletcher J Columbus R Saris CJ Ernst M Nicola NA Hilton DJ Alexander WS Starr R. 2007. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 110:2528-2536.
14. Bullock AN Debreczeni JE Edwards AM Sundstrom M Knapp S. 2006. Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase. Proc Natl Acad Sci USA 103:7637-7642.
15. Bullock AN Rodriguez MC Debreczeni JE Songyang Z Knapp S. 2007. Structure of the SOCS4-elonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCSdependent EGFR degradation. Structure 15:1493-1504.
16. Callus BA Mathey-Prevot B. 2002. SOCS36E a novel Drosophila SOCS protein suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc. Oncogene 21:4812-4821.
17. Cao W Yang YQ Wang ZY Liu AL Fang L Wu FL Hong J Shi YF Leung S Dong C Zhang JWZ. 2011. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 35:273-284.
18. Chen Z Laurence A Kanno Y Pacher-Zavisin M Zhu BM Tato C Yoshimura A Hennighausen L O'Shea JJ. 2006. Selective regulatory function of SOCS3 in the formation of IL-17- secreting T cells. Proc Natl Acad Sci USA 103:8137-8142.
19. ClahsenT,LehmannU Stross C,HermannsHM,Volkmer-EngertR Schneider-Mergener J Heinrich PC Schaper F. 2005. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling. Cell Signal 17:559-569.
20. Cohney SJ Sanden D Cacalano NA Yoshimura A Mui A Migone TS Johnston JA. 1999. SOCS-3 is tryrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol Cell Biol 19: 4980-4988.
21. Croker BA Krebs DL Zhang JG Wormald S Willson TA Stanley EG Robb L Greenhalgh CJ Forster I Clausen BE Nicola NA Metcalf D Hilton DJ Roberts AW Alexander WS. 2003. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4:540-545.
22. Croker BA Metcalf D Robb L Wei W Mifsud S DiRago L Cluse LA Sutherland KD Hartley L Williams E Zhang JG Hilton DJ Nicola NA Alexander WS Roberts AW. 2004. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20:153-165.
23. Croker BA Mielke LA Wormald S Metcalf D Kiu H Alexander WS Hilton DJ Roberts AW. 2008. SOCS3 maintains the specificity of biological responses to cytokine signals during granulocyte and macrophage differentiation. Exp Hematol 36: 786-798.
24. Croker BA Kiu H Pellegrini M Toe J Preston S Metcalf D O'Donnell JA Cengia LH McArthur K Nicola NA Alexander WS Roberts AW. 2011. IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. Immunol Cell Biol. 90(1):124-129.
25. Cui Q Jiang W Wang YX Lv C Luo JJ Zhang W Lin F Yin YX Cai R Wei P Qian C. 2008. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma. Hepatology 47:105-112.
26. De Souza D Fabri LJ Nash A Hilton DJ Nicola NA Baca M. 2002. SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities. Biochemistry 41:9229-9236.
27. Egwuagu CE Yu CR Zhang MF Mahdi RM Kim SJ Gery I. 2002. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: Implications for Th cell lineage commitment and maintenance. J Immunol 168: 3181-3187.
28. Emery B Cate HS Marriottt M Merson T Binder MD Snell C Soo PY Murray S Croker B Zhang JG Alexander WS Cooper H Butzkueven H Kilpatrick TJ. 2006a. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc Natl Acad Sci USA 103:7859-7864.
29. Emery B,Merson TD Snell C Young KM Ernst M Kilpatrick TJ. 2006b. SOCS3 negatively regulates LIF signaling in neural precursor cells. Mol Cell Neurosci 31:739-747.
30. Endo TA Masuhara M Yokouchi M Suzuki R Sakamoto H Mitsui K Matsumoto A Tanimura S Ohtsubo M Misawa H Miyazaki T Leonor N Taniguchi T Fujita T Kanakura Y Komiya S Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-924.
31. Ernst M Najdovska M Grail D Lundgren-May T Buchert M Tye H Matthews VB Armes J Bhathal PS Hughes NR Marcusson EG Karras JG Na SQ Sedgwick JD Hertzog PJ Jenkins BJ. 2008. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118:1727-1738.
32. Fairlie WD De Souza D Nicola NA Baca M. 2003. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2. Biochem J 372: 495-502.
33. Forrai A Boyle K Hart AH Hartley L Rakar S Willson TA Simpson KM Roberts AW Alexander WS Voss AK Robb L. 2006. Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells 24:604-614.
34. Greenhalgh CJ Metcalf D Thaus AL Corbin JE Uren R Morgan PO Fabri LJ Zhang JG Martin HM Willson TA Billestrup N Nicola NA Baca M Alexander WS Hilton DJ. 2002. Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling. J Biol Chem 277: 40181-40184.
35. Grucza RA Bradshaw JM Futterer K Waksman G. 1999. SH2 domains: From structure to energetics a dual approach to the study of structure-function relationships. Med Res Rev 19: 273-293.
36. Hilton DJ Richardson RT Alexander WS Viney EM Willson TA Sprigg NS Starr R Nicholson SE Metcalf D Nicola NA. 1998. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 95:114-119.
37. Hortner M Nielsch U Mayr LM Heinrich PC Haan S. 2002a. A new high affinity binding site for suppressor of cytokine signaling-3 on the erythropoietin receptor. Eur J Biochem 269: 2516-2526.
38. Hortner M Nielsch U Mayr LM Johnston JA Heinrich PC Haan S. 2002b. Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol 169:1219-1227.
39. Howard JK Cave BJ Oksanen LJ Tzameli I Bjorbaek C Flier JS. 2004. Enhanced leptin sensitivity and attenuation of dietinduced obesity in mice with haploinsufficiency of SOCS3. Nat Med 10:734-738.
40. Ihle JN Witthuhn BA Quelle FW Yamamoto K Thierfelder WE Kreider B Silvennoinen O. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19: 222-227.
41. Kamura T Maenaka K Kotoshiba S Matsumoto M Kohda D Conaway RC Conaway JW Nakayama KI. 2004. VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev 18:3055-3065.
42. Kario E Marmor MD Adamsky K Citri A Amit I Amariglio N Rechavi G Yarden Y. 2005. Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling. J Biol Chem 280:7038-7048.
43. Kievit P Howard JK Badman MK Balthasar N Coppari R Mori H Lee CE Elmquist JK Yoshimura A Flier JS. 2006. Enhanced leptin sensitivity and improved glucose homeostasis in mice lacking suppressor of cytokine signaling-3 in POMCexpressing cells. Cell Metab 4:123-132.
44. Kimura A Kinjyo I,Matsumura Y Mori H Mashima R Harada M Chien KR Yasukawa H Yoshimura A. 2004. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem 279:6905-6910.
45. Kinjyo I Inoue H Hamano S Fukuyama S Yoshimura T Koga K Takaki H Himeno K Takaesu G Kobayashi T Yoshimura A. 2006. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-beta 1. J Exp Med 203:1021-1031.
46. Ladbury JE Lemmon MA Zhou M Green J Botfield MC Schlessinger J. 1995. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: A reappraisal. Proc Natl Acad Sci USA 92:3199-3203.
47. Lang R Pauleau AL Parganas E Takahashi Y Mages J Ihle JN Rutschman R Murray PJ. 2003. SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 4:546-550.
48. Lucet IS Fantino E Styles M Bamert R Patel O Broughton SE Walter M Burns CJ Treutlein H Wilks AF Rossjohn J. 2006. The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor. Blood 107:176-183.
49. Mahrour N RedwineWB,Florens L Swanson SK,Martin-Brown S Bradford WD Staehling-Hampton K Washburn MP Conaway RC Conaway JW. 2008. Characterization of Cullin-box sequences that direct recruitment of Cul2-Rbx1 and Cul5-Rbx2 modules to elongin BC-based ubiquitin ligases. J Biol Chem 283: 8005-8013.
50. Matsumoto A Seki Y Watanabe R Hayashi K Johnston JA Harada Y Abe R Yoshimura A Kubo M. 2003. A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med 197: 425-436.
51. Matsumura Y Kobayashi T Ichiyama K Yoshida R Hashimoto M Takimoto T Tanaka K Chinen T Shichita T Wyss-Coray T Sato K Yoshimura A. 2007. Selective expansion of Foxp3- positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells. J Immunol 179:2170-2179.
52. Mori H Hanada R Hanada T Aki D Mashima R Nishinakamura H Torisu T Chien KR Yasukawa H Yoshimura A. 2004. SOCS3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10:739-743.
53. Naka T Narazaki M Hirata M Matsumoto T Minamoto S Aono A Nishimoto N Kajita T Taga T Yoshizaki K Akira S Kishimoto T. 1997. Structure and function of a new STATinduced STAT inhibitor. Nature 387:924-929.
54. Nicholson SE De Souza D Fabri LJ Corbin J Willson TA Zhang JG Silva A Asimakis M Farley A Nash AD Metcalf D Hilton DJ Nicola NA Baca M. 2000. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci USA 97:6493-6498.
55. Nicholson SE Metcalf D Sprigg NS Columbus R Walker F Silva A Cary D Willson TA Zhang JG Hilton DJ Alexander WS Nicola NA. 2005. Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling. Proc Natl Acad Sci USA 102:2328-2333.
56. Niwa Y Kanda H Shikauchi Y Saiura A Matsubara K Kitagawa T Yamamoto J Kubo T Yoshikawa H. 2005. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STATand FAK signalings in human hepatocellular carcinoma. Oncogene 24:6406-6417.
57. Ogata H Chinen T Yoshida T Kinjyo I Takaesu G Shiraishi H Iida M Kobayashi T Yoshimura A. 2006a. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGFbeta 1 production. Oncogene 25:2520-2530.
58. Ogata H Kobayashi T Chinen T Takaki H Sanada T Minoda Y Koga K Takaesu G Maehara Y Iida M Yoshimura A. 2006b. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 131: 179-193.
59. Ohh M Takagi Y Aso T Stebbins CE Pavletich NP Zbar B Conaway RC Conaway JW Kaelin WG Jr. 1999. Synthetic peptides define critical contacts between elongin C elongin B and the von Hippel-Lindau protein. J Clin Invest 104: 1583-1591.
60. Ohh M Park CW Ivan M Hoffman MA Kim TY Huang LE Pavletich N Chau V Kaelin WG. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the betadomain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427.
61. Pazienza V Clement S Pugnale P Conzelman S Foti M Mangia A Negro F. 2007. The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 45:1164-1171.
62. Pellegrini M Calzascia T Toe JG Preston SP Lin AE Elford AR Shahinian A Lang PA Lang KS MorreM Assouline B Lahl K Sparwasser T Tedder TF Paik JH DePinho RA Basta S Ohashi PS Mak TW. 2011. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144:601-613.
63. Pillemer BBL Xu H Oriss TB Qi ZB Ray A. 2007. Deficient SOCS3 expression in CD4()CD25()FoxP3() regulatory T cells and SOCS3-mediated suppression of Treg function. Eur J Immunol 37:2082-2089.
64. Qin HW Wang LF Feng T Elson CO Niyongere SA Lee SJ Reynolds SL Weaver CT Roarty K Serra R Benveniste EN Cong YZ. 2009. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J Immunol 183:97-105.
65. Ram PA Waxman DJ. 1999. SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274:35553-35561.
66. Ram PA Waxman DJ. 2000. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone. J Biol Chem 275:39487-39496.
67. Riehle KJ Campbell JS McMahan RS Johnson MM Beyer RP Bammler TK Fausto N. 2008. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 205:91-103.
68. Robb L Boyle K Rakar S Hartley L Lochland J Roberts AW Alexander WS Metcalf D. 2005. Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc Natl Acad Sci USA 102: 16333-16338.
69. Roberts AW Robb L Rakar S Hartley L Cluse L Nicola NA Metcalf D Hilton DJ Alexander WS. 2001. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA 98:9324-9329.
70. Rogers S Wells R Rechsteiner M. 1986. Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis. Science 234:364-368.
71. Sasaki A Yasukawa H Suzuki A Kamizono S Syoda T Kinjyo I Sasaki M Johnston JA Yoshimura A. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339-351.
72. Schmitz J,Weissenbach M Haan S Heinrich PC Schaper F. 2000. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 275:12848-12856.
73. Seki Y Inoue H Nagata N Hayashi K Fukuyama S Matsumoto K Komine O Hamano S Himeno K Inagaki-Ohara K Cacalano N O'Garra A Oshida T Saito H Johnston JA Yoshimura A Kubo M. 2003. SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med 9: 1047-1054.
74. Shouda T Yoshida T Hanada T Wakioka T Oishi M Miyoshi K Komiya S Kosai K Hanakawa Y Hashimoto K Nagata K Yoshimura A. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 108:1781-1788.
75. Smith PD Sun F Park KK Cai B Wang C Kuwako K Martinez-Carrasco I Connolly L He G. 2009. SOCS3 Deletion promotes optic nerve regeneration in vivo. Neuron 64:617-623.
76. Song MM Shuai K. 1998. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J Biol Chem 273:35056-35062.
77. Starr R Willson TA Viney EM Murray LJ Rayner JR Jenkins BJ Gonda TJ Alexander WS Metcalf D Nicola NA Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-921.
78. Stross C Radtke S Clahsen T Gerlach C Volkmer-Engert R Schaper F Heinrich PC Hermanns HM. 2006. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism. J Biol Chem 281:8458-8468.
79. Sun F Park KK Belin S Wang D Lu T Chen G Zhang K Yeung C Feng G Yankner BA He Z. 2011. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480(7377):372-375.
80. Takahashi Y Carpino N Cross JC Torres M Parganas E Ihle JN. 2003. SOCS3: An essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 22:372-384.
81. Takahashi Y Dominici M Swift J Nagy C Ihle JN. 2006.Trophoblast stem cells rescue placental defect in SOCS3- deficient mice. J Biol Chem 281:11444-11445.
82. Taleb S Romain M Ramkhelawon B Uyttenhove C Pasterkamp G Herbin O Esposito B Perez N Yasukawa H Van Snick J Yoshimura A Tedgui A Mallat Z. 2009. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206:2067-2077.
83. Verdier F Chretien S Muller O Varlet P Yoshimura A Gisselbrecht S Lacombe C Mayeux P. 1998. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J Biol Chem 273: 28185-28190.
84. Waksman G Shoelson SE Pant N Cowburn D Kuriyan J. 1993. Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms. Cell 72:779-790.
85. Wilks AF Oates AC. 1996. The JAK/STAT pathway. Cancer Surv 27:139-163.
86. Wisniewski JA Borish L. 2011. Novel cytokines and cytokineproducing T cells in allergic disorders. Allergy Asthma Proc 32: 83-94.
87. Wong PKK Egan PJ Croker BA O'Donnell K Sims NA Drake S Kiu H McManus EJ Alexander WS Roberts AW Wicks IP. 2006. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 116:1571-1581.
88. Wormald S Zhang JG Krebes DL Mielke LA Silver J Alexander WS Speed TP Nicola NA Hilton DJ. 2006. The comparative roles of suppressor of cytokine signaling-1 and-3 in the inhibition and desensitization of cytokine signaling. J Biol Chem 281:11135-11143.
89. Yamamoto K YamaguchiM Miyasaka N Miura O. 2003. SOCS-3 inhibits IL-12-induced STAT4 activation by binding through its SH2 domain to the STAT4 docking site in the IL-12 receptor beta 2 subunit. Biochem Biophys Res Commun 310: 1188-1193.
90. Yasukawa H Misawa H Sakamoto H Masuhara M Sasaki A Wakioka T Ohtsuka S Imaizumi T Matsuda T Ihle JN Yoshimura A. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 18:1309-1320.
91. Yoshikawa H Matsubara K Qian GS Jackson P Groopman JD Manning JE Harris CC Herman JG. 2001. SOCS-1 a negative regulator of the JAK/STAT pathway is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28:29-35.
92. Yasukawa H Ohishi M Mori H Murakami M Chinen T Aki D Hanada T Takeda K Akira S Hoshijima M Hirano T Chien KR Yoshimura A. 2003. IL-6 induces an antiinflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 4:551-556.
93. Zhang JG Metcalf D Rakar S Asimakis M Greenhalgh CJ Willson TA Starr R Nicholson SE Carter W Alexander WS Hilton DJ Nicola NA. 2001. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc Natl Acad Sci USA 98:13261-13265.
94. Zhang R Dhillon H Yin H Yoshimura A Lowell BB Maratos-Flier E Flier JS. 2008. Selective inactivation of SOCS3 in SF1 neurons improves glucose homeostasis without affecting body weight. Endocrinology 149:5654-5661.
95. Zheng N Schulman BA Song L Miller JJ Jeffrey PD Wang P Chu C Koepp DM Elledge SJ Pagano M Conaway RC Conaway JW Harper JW Pavletich NP. 2002. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416:703-709.